Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Stomach Neoplasms 8Barrett Esophagus 7Gastritis 5Breast Neoplasms 4Stomach Ulcer 3Peptic Ulcer 3Gastroesophageal Reflux 3Dyspepsia 3Zollinger-Ellison Syndrome 2Esophageal Neoplasms 2Colorectal Neoplasms 2Vomiting 1Radiation Esophagitis 1Precancerous Conditions 1Peptic Ulcer Hemorrhage 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Esophagitis 1Dysbiosis 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Fulvestrant 5Exercise 5Eating 5Standard of Care 3Sodium Chloride 3Diet 3Alpelisib 3ribociclib 2gallium Ga 68 dotatate 2exemestane 2Vitamin D 2Tamoxifen 2Magnetic Resonance Spectroscopy 2Letrozole 2Ethanol 2Blood Specimen Collection 2Anastrozole 2zopiclone 1ziprasidone 1veliparib 1testosterone undecanoate 1testosterone enanthate 1pazopanib 1mirabegron 1methyl hydroxyethyl cellulose 1lenvatinib 1fluorocholine 1evolocumab 1dimethandrolone-undecanoate 1cyclopropapyrroloindole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Endocrine Neoplasia Type 1 × Esomeprazole × Clear all
NCT05061563 2022-03-17

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Bayer

Phase 1 Completed
14 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡